736 related articles for article (PubMed ID: 26058518)
21. Hepatocyte X-box binding protein 1 deficiency increases liver injury in mice fed a high-fat/sugar diet.
Liu X; Henkel AS; LeCuyer BE; Schipma MJ; Anderson KA; Green RM
Am J Physiol Gastrointest Liver Physiol; 2015 Dec; 309(12):G965-74. PubMed ID: 26472223
[TBL] [Abstract][Full Text] [Related]
22. Extracellular vesicles derived from fat-laden hepatocytes undergoing chemical hypoxia promote a pro-fibrotic phenotype in hepatic stellate cells.
Hernández A; Reyes D; Geng Y; Arab JP; Cabrera D; Sepulveda R; Solis N; Buist-Homan M; Arrese M; Moshage H
Biochim Biophys Acta Mol Basis Dis; 2020 Oct; 1866(10):165857. PubMed ID: 32512191
[TBL] [Abstract][Full Text] [Related]
23. Fucoxanthin inhibits hepatic oxidative stress, inflammation, and fibrosis in diet-induced nonalcoholic steatohepatitis model mice.
Takatani N; Kono Y; Beppu F; Okamatsu-Ogura Y; Yamano Y; Miyashita K; Hosokawa M
Biochem Biophys Res Commun; 2020 Jul; 528(2):305-310. PubMed ID: 32475638
[TBL] [Abstract][Full Text] [Related]
24. Epigallocatechin gallate attenuated non-alcoholic steatohepatitis induced by methionine- and choline-deficient diet.
Ding Y; Sun X; Chen Y; Deng Y; Qian K
Eur J Pharmacol; 2015 Aug; 761():405-12. PubMed ID: 25967348
[TBL] [Abstract][Full Text] [Related]
25. Hepatocyte Ninjurin2 promotes hepatic stellate cell activation and liver fibrosis through the IGF1R/EGR1/PDGF-BB signaling pathway.
Wang Y; Wang P; Yu Y; Huang E; Yao Y; Guo D; Peng H; Tian B; Zheng Q; Jia M; Wang J; Wu X; Cheng J; Liu H; Wang QK; Xu C
Metabolism; 2023 Mar; 140():155380. PubMed ID: 36549436
[TBL] [Abstract][Full Text] [Related]
26. p53/p66Shc-mediated signaling contributes to the progression of non-alcoholic steatohepatitis in humans and mice.
Tomita K; Teratani T; Suzuki T; Oshikawa T; Yokoyama H; Shimamura K; Nishiyama K; Mataki N; Irie R; Minamino T; Okada Y; Kurihara C; Ebinuma H; Saito H; Shimizu I; Yoshida Y; Hokari R; Sugiyama K; Hatsuse K; Yamamoto J; Kanai T; Miura S; Hibi T
J Hepatol; 2012 Oct; 57(4):837-43. PubMed ID: 22641095
[TBL] [Abstract][Full Text] [Related]
27. The indole derivative NecroX-7 improves nonalcoholic steatohepatitis in ob/ob mice through suppression of mitochondrial ROS/RNS and inflammation.
Chung HK; Kim YK; Park JH; Ryu MJ; Chang JY; Hwang JH; Lee CH; Kim SH; Kim HJ; Kweon GR; Kim KS; Shong M
Liver Int; 2015 Apr; 35(4):1341-53. PubMed ID: 25443620
[TBL] [Abstract][Full Text] [Related]
28. Reduction of endotoxin attenuates liver fibrosis through suppression of hepatic stellate cell activation and remission of intestinal permeability in a rat non-alcoholic steatohepatitis model.
Douhara A; Moriya K; Yoshiji H; Noguchi R; Namisaki T; Kitade M; Kaji K; Aihara Y; Nishimura N; Takeda K; Okura Y; Kawaratani H; Fukui H
Mol Med Rep; 2015 Mar; 11(3):1693-700. PubMed ID: 25421042
[TBL] [Abstract][Full Text] [Related]
29. Necroptosis is a key pathogenic event in human and experimental murine models of non-alcoholic steatohepatitis.
Afonso MB; Rodrigues PM; Carvalho T; Caridade M; Borralho P; Cortez-Pinto H; Castro RE; Rodrigues CM
Clin Sci (Lond); 2015 Oct; 129(8):721-39. PubMed ID: 26201023
[TBL] [Abstract][Full Text] [Related]
30. IFN-γ deficiency attenuates hepatic inflammation and fibrosis in a steatohepatitis model induced by a methionine- and choline-deficient high-fat diet.
Luo XY; Takahara T; Kawai K; Fujino M; Sugiyama T; Tsuneyama K; Tsukada K; Nakae S; Zhong L; Li XK
Am J Physiol Gastrointest Liver Physiol; 2013 Dec; 305(12):G891-9. PubMed ID: 24136786
[TBL] [Abstract][Full Text] [Related]
31. Loss of cellular FLICE-inhibitory protein promotes acute cholestatic liver injury and inflammation from bile duct ligation.
Gehrke N; Nagel M; Straub BK; Wörns MA; Schuchmann M; Galle PR; Schattenberg JM
Am J Physiol Gastrointest Liver Physiol; 2018 Mar; 314(3):G319-G333. PubMed ID: 29191940
[TBL] [Abstract][Full Text] [Related]
32. Ets-1 deficiency alleviates nonalcoholic steatohepatitis via weakening TGF-β1 signaling-mediated hepatocyte apoptosis.
Liu D; Wang K; Li K; Xu R; Chang X; Zhu Y; Sun P; Han X
Cell Death Dis; 2019 Jun; 10(6):458. PubMed ID: 31189885
[TBL] [Abstract][Full Text] [Related]
33. Raloxifene Ameliorates Liver Fibrosis of Nonalcoholic Steatohepatitis Induced by Choline-Deficient High-Fat Diet in Ovariectomized Mice.
Luo F; Ishigami M; Achiwa K; Ishizu Y; Kuzuya T; Honda T; Hayashi K; Ishikawa T; Katano Y; Goto H
Dig Dis Sci; 2015 Sep; 60(9):2730-9. PubMed ID: 25868633
[TBL] [Abstract][Full Text] [Related]
34. Glucose fluctuation increased hepatocyte apoptosis under lipotoxicity and the involvement of mitochondrial permeability transition opening.
Yin X; Zheng F; Pan Q; Zhang S; Yu D; Xu Z; Li H
J Mol Endocrinol; 2015 Dec; 55(3):169-81. PubMed ID: 26464382
[TBL] [Abstract][Full Text] [Related]
35. Hepatocyte Notch activation induces liver fibrosis in nonalcoholic steatohepatitis.
Zhu C; Kim K; Wang X; Bartolome A; Salomao M; Dongiovanni P; Meroni M; Graham MJ; Yates KP; Diehl AM; Schwabe RF; Tabas I; Valenti L; Lavine JE; Pajvani UB
Sci Transl Med; 2018 Nov; 10(468):. PubMed ID: 30463916
[TBL] [Abstract][Full Text] [Related]
36. Vitronectin deficiency attenuates hepatic fibrosis in a non-alcoholic steatohepatitis-induced mouse model.
Hayashida M; Hashimoto K; Ishikawa T; Miyamoto Y
Int J Exp Pathol; 2019 Apr; 100(2):72-82. PubMed ID: 30887659
[TBL] [Abstract][Full Text] [Related]
37. c-Met Signaling Protects from Nonalcoholic Steatohepatitis- (NASH-) Induced Fibrosis in Different Liver Cell Types.
Drescher HK; Schumacher F; Schenker T; Baues M; Lammers T; Hieronymus T; Trautwein C; Streetz KL; Kroy DC
Oxid Med Cell Longev; 2018; 2018():6957497. PubMed ID: 30538805
[TBL] [Abstract][Full Text] [Related]
38. Activin-A causes Hepatic stellate cell activation via the induction of TNFα and TGFβ in Kupffer cells.
Kiagiadaki F; Kampa M; Voumvouraki A; Castanas E; Kouroumalis E; Notas G
Biochim Biophys Acta Mol Basis Dis; 2018 Mar; 1864(3):891-899. PubMed ID: 29287776
[TBL] [Abstract][Full Text] [Related]
39. Micro-RNA 21 inhibition of SMAD7 enhances fibrogenesis via leptin-mediated NADPH oxidase in experimental and human nonalcoholic steatohepatitis.
Dattaroy D; Pourhoseini S; Das S; Alhasson F; Seth RK; Nagarkatti M; Michelotti GA; Diehl AM; Chatterjee S
Am J Physiol Gastrointest Liver Physiol; 2015 Feb; 308(4):G298-312. PubMed ID: 25501551
[TBL] [Abstract][Full Text] [Related]
40. Pharmaceutical Efficacy of Gypenoside LXXV on Non-Alcoholic Steatohepatitis (NASH).
Lee JH; Oh JY; Kim SH; Oh IJ; Lee YH; Lee KW; Lee WH; Kim JH
Biomolecules; 2020 Oct; 10(10):. PubMed ID: 33050067
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
